Intellia Therapeutics, Inc. License Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
2023
Invention Management Agreement for Programmable DNA Restriction Enzyme (CRISPR) – Charpentier, Regents of UC, Vienna, CRISPR Therapeutics, ERS Genomics, TRACR, Caribou, Intellia
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
CA
2022
Third Amendment to License and Collaborative Research Agreement between Novartis Institutes for BioMedical Research, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2021
License and Collaborative Research Agreement between Novartis Institutes for BioMedical Research, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2021
Exclusive Cross-License Agreement between Caribou Biosciences, Inc. and Intellia, LLC (July 16, 2014)
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2021
Amendment to License and Collaborative Research Agreement between Novartis Institutes for BioMedical Research, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2019
Invention Management Agreement for Programmable DNA Restriction Enzyme (CRISPR) Among Charpentier, Regents of UC, University of Vienna, CRISPR Therapeutics, ERS Genomics, TRACR...
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
CA
2016
License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. (April 11, 2016)
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2016
License and Collaborative Research Agreement between Novartis Institutes for BioMedical Research, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2016
Confidential License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. (April 11, 2016)
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2016
License and Collaborative Research Agreement between Novartis Institutes for BioMedical Research, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2016
Exclusive Cross-License Agreement between Caribou Biosciences, Inc. and Intellia, LLC (July 16, 2014)
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2016
Confidential License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. (April 11, 2016)
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2016
Addendum to License Agreement between Caribou Biosciences, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
2016
Amendment No. 1 to License Agreement between Caribou Biosciences, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
2016
License and Collaborative Research Agreement between Novartis Institutes for BioMedical Research, Inc. and Intellia Therapeutics, Inc.
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2016
License Agreement between Caribou Biosciences, Inc. and Intellia, LLC (July 16, 2014)
License Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2016